advertisement
Editors Selection IGR 26-1
List of Editor's Selection comments by
Horacio Uri Saragovi
Lady Davis Institute for Medical Research, Sir Mortimer B. Davis-Jewish General Hospital, Montreal, Quebec, Canada
Experimental Glaucoma: Neuroprotection (14-3, April 2013) on:
50979 Etanercept, a widely used inhibitor of tumor necrosis factor-α (TNF-α), prevents retinal ganglion cell loss in a rat model of glaucoma
Roh M; Zhang Y; Murakami Y et al.
PLoS ONE 2012; 7: e40065
